National Comprehensive Cancer Network



About NCCN

Thyroid Carcinoma Panel - Disclosures as of 4/24/2014

View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures

Panel Member Clinical Research Support/Data Safety Monitoring Board Advisory Boards, Speakers Bureau, Expert Witness, or Consultant Patent, Equity, or Royalty Other Date Completed

Douglas W. Ball, MD

Eisai Inc.;
Exelixis Inc.;
Roche USA

Exelixis Inc.

None

None

12/7/2011

David Byrd, MD

None

None

None

None

3/4/2013

Paxton Dickson, MD

None

None

None

None

10/3/2013

Quan-Yang Duh, MD

None

None

None

None

10/2/2013

Hormoz Ehya, MD

None

Eli Lilly and Company

None

None

1/30/2014

Fayna Ferkle, PharmD

None

None

None

None

3/26/2014

Lauren Gallagher, RPh, PhD

None

None

None

None

6/18/2013

Kristina M. Gregory, RN, MSN, OCN

None

None

None

None

10/23/2013

Robert I. Haddad, MD

None

None

None

None

5/29/2013

Megan Haymart, MD

None

None

None

None

10/2/2013

Karin Hoffmann, RN

None

None

None

None

8/13/2013

Carl Hoh, MD

None

None

None

None

10/3/2013

Miranda Hughes, PhD

None

None

None

None

4/21/2014

Jason P. Hunt, MD

None

None

None

None

6/26/2013

Andrei Iagaru, MD

None

None

None

None

3/14/2013

Fouad Kandeel, MD, PhD

None

None

None

None

8/17/2012

Peter Kopp, MD

None

None

None

American Thyroid Association;
Editor in Chief: Thyroid. Official Journal American Thyroid Association

10/2/2013

Dominick M. Lamonica, MD

None

None

None

None

6/18/2012

William M. Lydiatt, MD

None

None

None

None

5/29/2013

Judith C. McCaffrey, MD

None

None

None

None

7/26/2012

Joan S. McClure, MS

None

None

None

None

8/13/2013

Nicole McMillian, MS

None

None

None

None

3/9/2014

Jeffrey F. Moley, MD

AstraZeneca Pharmaceuticals LP;
Exelixis Inc.

Exelixis Inc.

None

None

10/8/2012

Lee Parks, MD

AstraZeneca Pharmaceuticals LP

None

None

None

12/5/2013

Christopher D. Raeburn, MD

None

None

None

None

9/28/2013

John A. Ridge, MD, PhD, FACS

None

None

None

None

10/4/2013

Matthew Ringel, MD

National Cancer Institute

None

None

International Thyroid Oncology Group

5/29/2013

Randall P. Scheri, MD

None

None

None

None

6/4/2013

Jatin P. Shah, MD, PhD

None

None

None

None

10/2/2013

Steven I. Sherman, MD

Genzyme Corporation;
National Cancer Institute;
Pfizer Inc.

Amgen Inc.;
Bayer HealthCare;
Eisai Inc.;
Eli Lilly and Company;
Exelixis Inc.;
Novo Nordisk;
Veracyte

None

None

10/2/2013

Cord Sturgeon, MD

None

None

None

None

10/3/2013

R. Michael Tuttle, MD

None

AstraZeneca Pharmaceuticals LP;
Bayer HealthCare;
Exelixis Inc.;
Genzyme Corporation;
Novo Nordisk;
Veracyte

None

None

1/28/2014

Steven G. Waguespack, MD

None

None

None

None

9/29/2013

Thomas N. Wang, MD, PhD

None

None

None

None

9/30/2013

Lori J. Wirth, MD

AstraZeneca Pharmaceuticals LP;
Eisai Inc.;
Exelixis Inc.

Amgen Inc.;
Bayer HealthCare;
Exelixis Inc.;
Novartis Pharmaceuticals Corporation

None

AstraZeneca Pharmaceuticals LP;
Eisai Inc.

10/7/2013